Jump to main content
Jump to site search
PLANNED MAINTENANCE Close the message box

Scheduled maintenance work on Wednesday 21st October 2020 from 07:00 AM to 07:00 PM (BST).

During this time our website performance may be temporarily affected. We apologise for any inconvenience this might cause and thank you for your patience.


Issue 1, 2013
Previous Article Next Article

On the importance of synthetic organic chemistry in drug discovery: reflections on the discovery of antidiabetic agent ertugliflozin§

Author affiliations

Abstract

The discovery of antidiabetic agent ertugliflozin is described. The compound belongs to a new class of SGLT2 inhibitors bearing a dioxa-bicyclo[3.2.1]octane motif. This article describes the critical role that organic synthesis played in both influencing our medicinal chemistry strategy and speeding up the progression of our program.

Graphical abstract: On the importance of synthetic organic chemistry in drug discovery: reflections on the discovery of antidiabetic agent ertugliflozin

Back to tab navigation

Supplementary files

Article information


Submitted
24 Jun 2012
Accepted
11 Jul 2012
First published
16 Jul 2012

Med. Chem. Commun., 2013,4, 101-111
Article type
Concise Article

On the importance of synthetic organic chemistry in drug discovery: reflections on the discovery of antidiabetic agent ertugliflozin

V. Mascitti, B. A. Thuma, A. C. Smith, R. P. Robinson, T. Brandt, A. S. Kalgutkar, T. S. Maurer, B. Samas and R. Sharma, Med. Chem. Commun., 2013, 4, 101
DOI: 10.1039/C2MD20163A

Search articles by author

Spotlight

Advertisements